semaglutide 5mg weight control lowering blood glucose and lipids
TDS 10 Inquiries
63958-90-7
Pharmaceutical Grade
99%
shenzhen
subi
10mg/vial, 10vials/kit
Yes
2026-05-30
peptone
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceA thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation.Certificates
-
TDS
Basic Info-
Product Name:
SERUM THYMIC FACTOR
Other Name:5-Oxo-L-Pro-L-Ala-L-Lys-L-Ser-L-Gln-Gly-Gly-L-Ser-L-Asn-OH;pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn;STF, SeruM ThyMic Factor, ThyMulin;Serum thymic factor (porcine);Thymic serum factor;Thymic serum factor (pig);L-Asparagine,5-oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-;Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH trifluoroacetate salt
CAS No.:63958-90-7
Molecular Formula:C33H54N12O15
InChIKeys:LIFNDDBLJFPEAN-BPSSIEEOSA-N
Molecular Weight:858.85
Exact Mass:858.38300
UNII:9H198D04WL
DSSTox ID:DTXSID10213801
Categories:
Characteristics-
PSA:
452
XLogP3:-10.9
Appearance:white
Density:1.417 g/cm33
Boiling Point:1658.9ºC at 760 mmHg
Flash Point:957.1ºC
Refractive Index:1.575
Water Solubility:deionized water: soluble
Storage Conditions:−20°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptone
-
Location:
Room A109, No. 29 Dongting Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
3 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2024
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
United States
Zinc Thymulin 98% 63958-90-7
10 G Jan 28, 2025
Netherlands
Zinc Thymulin 98% Powder 63958-90-7
10 G Apr 6, 2024
United States
Zinc Thymulin 98% 63958-90-7
100 G Feb 10, 2025
United States
Zinc Thymulin 98% 63958-90-7
100 G Jan 28, 2025
United States
Zinc thymulin
3 G Sep 2, 2026
United States
zinc thymulin
25 MG Aug 11, 2026
United States
Zinc-Thymulin
1000 KG Feb 25, 2026
United States
Zinc Thymulin
1 Jul 17, 2025
Kenya
Zinc thymulin
1 KG Jul 17, 2026
United States
Zinc Thymulin 98% Powder
1 G Feb 16, 2024 Post an enquiry for this product
More from this Seller
-
-
-
trans-4-hydroxy-3-methoxycinnamic acid human with Safe Delivery
Industrial Grade / 99%
-
-
-
-
2-Chloro-5-methylpyridine factory direct white raw powder high quality
Pharmaceutical Grade / 99%
-
-
-
-
High purity 99% 2-Ethylthiophene human with Safe Delivery
Industrial Grade / 99%
-
-
-
-
Glycyl-L-glutamine monohydrate hot sale high purity white powder
Pharmaceutical Grade / 99%
-
-
-
-
3-chloro-5-nitropyridine hot sale high quality white raw powder
Industrial Grade / 99%
-
-
-
-
20 Years Factory Supply High Purity Glutathione CAS 70-18-8 from China
Industrial Grade / 99%
-